NCT06197906View on ClinicalTrials.gov

Effectiveness and Safety of the RIGHTEST™ Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
Diabetes Mellitus
Interventions
DEVICE

Device implant

subcutaneous device implanting

Sponsors
All Listed Sponsors
lead

Bionime Corporation

INDUSTRY